Krishna Vaddi, CEO: Prelude Therapeutics PRLD Buy · Filed 23/05/25

Trade details

Type: Insider buy
Amount: $66,749.28
Shares · price: 11,856 sh · $5.63 a share
Held after: 1,065,375 sh
Stock: Prelude Therapeutics PRLD
Person: Krishna VaddiCEO
Trade date: 23/05/23
Filed: 23/05/25
Days to filing: 2 days

7 insiders bought this week

Insiders buying this week: 7 insiders
Holding change: +1.1%

Prelude Therapeutics trades, last 26 weeks

What else happened in Prelude Therapeutics around then

Filed or reported within 30 days of the trade day · 23/04/23~23/06/22

Krishna Vaddi's recent trades

Krishna VaddiCEO
BuyPrelude Therapeutics
Buy
Prelude Therapeutics
PRLD
$465.8K
675,000 sh
$465.8K
Filed 25/03/27
Traded 25/03/25
Krishna VaddiCEO
BuyPrelude Therapeutics
Buy
Prelude Therapeutics
PRLD
$11K
15,000 sh
$11K
Filed 25/03/24
Traded 25/03/21
Krishna VaddiCEO
BuyPrelude Therapeutics
Buy
Prelude Therapeutics
PRLD
$3,954
5,416 sh
$3,954
Filed 25/03/24
Traded 25/03/20
Krishna VaddiCEO
BuyPrelude Therapeutics
Buy
Prelude Therapeutics
PRLD
$22.5K
29,999 sh
$22.5K
Filed 25/03/18
Traded 25/03/14
Krishna VaddiCEO
BuyPrelude Therapeutics
Buy
Prelude Therapeutics
PRLD
$6,830
9,106 sh
$6,830
Filed 25/03/18
Traded 25/03/17